Skip to main content

HRB National Drugs Library

Home > A review of the evidence on the use and harms of Diphenidine and other related substances.

Advisory Council on the Misuse of Drugs. (2023) A review of the evidence on the use and harms of Diphenidine and other related substances. London: Advisory Council on the Misuse of Drugs.

[img]
Preview
 PDF (A review of the evidence on the use and harms of Diphenidine and other related substances) - Published Version
427kB
[img]
Preview
 PDF (Home Office letter - response to ACMD, August 2023) - Supplemental Material
126kB

This report reviews the evidence of use and harms - diphenidine, methoxyphenidine, fluorolintane, isophenidine and ephenidine and considers whether these compounds merit control under the Misuse of Drugs Act 1971 rather than the Psychoactive Substances Act 2016.

Item Type
Report
Publication Type
International, Review
Drug Type
New psychoactive substance
Intervention Type
Prevention, Harm reduction
Date
25 May 2023
Pages
36 p.
Publisher
Advisory Council on the Misuse of Drugs
Corporate Creators
Advisory Council on the Misuse of Drugs
Place of Publication
London
EndNote
View
Subjects
A Substance use and dependence > Prevalence > Problem substance use
B Substances > New (novel) psychoactive substances
B Substances > New (novel) psychoactive substances > Aminoindanes / Arylalkylamines / Arylcyclohexylamines > Ketamine
E Concepts in biomedical areas > Pharmacology and toxicology
MM-MO Crime and law > Substance use laws > Drug laws
MP-MR Policy, planning, economics, work and social services > Policy > Policy on substance use > Harm reduction policy
P Demography, epidemiology, and history > Population dynamics > Substance related mortality / death
VA Geographic area > Europe > United Kingdom

Repository Staff Only: item control page